Last Updated: 12/03/2025
Production of Standardised Reagents to Support Pv serology Dx development
Objectives
To demonstrate that plasmodium vivax Serology screen and treat (SeroTaT) can accelerate the elimination of plasmodium vivax malaria and provide countries with easy-to-use tools for this purpose.
Principal Institution
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia
Principal Investigators / Focal Persons
External reference
Date
Aug 2023 — Sep 2025
Total Project Funding
$782,618
Funding Details
Gates Foundation (GF), United States
Grant ID: INV-051542
Project Site
Related Resources
